Your browser doesn't support javascript.
loading
Left-sided valvular heart disease and retinopathy in a 38-year-old woman with attenuated mucopolysaccharidosis: a case report.
Asumda, Faizal Z; Kraker, Jessica A; Thomas, Sarah C; Maleszewski, Joseph; Stone, Edwin M; Lanpher, Brendan C; Schimmenti, Lisa A.
Afiliação
  • Asumda FZ; Department of Pediatrics and Pathology, Medical College of Georgia - Augusta University Medical Center, Augusta, GA, USA.
  • Kraker JA; Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA.
  • Thomas SC; Department of Pathology, Mayo Clinic, Rochester, MN, USA.
  • Maleszewski J; Department of Pathology, Mayo Clinic, Rochester, MN, USA.
  • Stone EM; Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, IA, USA.
  • Lanpher BC; Department of Clinical Genetics, Mayo Clinic, Rochester, MN, USA.
  • Schimmenti LA; Department of Clinical Genetics, Mayo Clinic, 201 1st St SW, Rochester, MN 55905, USA.
Ther Adv Rare Dis ; 4: 26330040221145945, 2023.
Article em En | MEDLINE | ID: mdl-37181073
• A 38-year-old woman with heart failure had heart valve surgery. Examining her cardiac valve tissue under the microscope suggested a metabolic disorder called mucopolysaccharidosis type I (MPS I). • MPS I is due to defective breakdown of sugar molecules (called glycosaminoglycans or GAGs for short) in the body which then can accumulate, causing dysfunction. • Our patient had short stature, a curved spine, stiff joints, and a degenerative eye disease called retinitis pigmentosa, all of which were due to her undiagnosed MPS I. • Most patients with MPS I are discovered on newborn screening when they are babies, or at very young ages due to severe symptoms related to the disease. • Our patient had a form of MPS I that was less severe, and the first symptom she received medical care for was her eye symptoms. • A diagnosis of MPS I made in middle adulthood is unusual for MPS I, and so is an important learning case for providers as there were clues hidden in her medical history that suggested a genetic or inherited syndrome. • Our genetics specialists were able to make a definitive diagnosis of MPS I and begin treatment with enzyme replacement therapy, as well as provide information for the patient about her risk of passing this disease on to children.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Ther Adv Rare Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Ther Adv Rare Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos